Close

Catalyst Biosciences (CBIO) Reports $1.5 MillionMilestone Payments for Neuronal Nicotinic Receptor (NNR) Asset

March 26, 2018 8:01 AM EDT Send to a Friend
Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that it has received $1.5 million in milestone payments following the completion of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login